Bacil Pharma Limited (BOM:524516)

Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	601	610	86	32	34	18
Market Cap Growth	330.59%	607.73%	166.97%	-4.36%	83.65%	89.09%
Enterprise Value	585	610	83	28	33	17
Last Close Price	41.86	42.49	14.63	5.48	5.73	3.12
PE Ratio	67.63	150.92	-	-	-	-
PB Ratio	2.28	2.40	7.10	2.94	2.76	1.32
P/TBV Ratio	2.28	2.40	7.10	2.94	2.76	1.32
P/FCF Ratio	-	152.16	-	-	-	-
P/OCF Ratio	-	152.16	-	-	-	-
EV/FCF Ratio	-	152.28	-	-	-	-
Debt / Equity Ratio	-	0.01	0.08	0.02	0.03	0.13
Debt / FCF Ratio	-	0.41	-	-	-	-
Net Debt / Equity Ratio	-0.06	-0.11	0.05	-0.18	-0.22	-0.04
Net Debt / EBITDA Ratio	5.68	10.67	-0.30	1.12	1.76	0.39
Net Debt / FCF Ratio	-	-6.72	-19.64	1.35	0.07	0.16
Quick Ratio	6.99	16.92	0.37	7.87	6.49	0.09
Current Ratio	13.36	17.21	0.46	8.19	6.69	0.11
Return on Equity (ROE)	4.54%	3.03%	-5.11%	-8.77%	-295.12%	-17.22%
Return on Assets (ROA)	-1.23%	-1.18%	-9.62%	-9.37%	-3.70%	-2.54%
Return on Invested Capital (ROIC)	-0.87%	-2.09%	-17.40%	-19.41%	-13.92%	-12.52%
Return on Capital Employed (ROCE)	-1.10%	-1.00%	-15.60%	-16.30%	-13.00%	-12.00%
Earnings Yield	1.06%	0.66%	-0.69%	-3.16%	-114.37%	-13.02%
FCF Yield	-	0.66%	-0.03%	-4.57%	-118.79%	-21.66%
Buyback Yield / Dilution	-71.68%	-6.92%	1.47%	-1.71%	-0.99%	0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.